Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | 36,518.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,518.00 |
| Dec 31, 2025 | 116,374.00 |
| Sep 30, 2025 | 59,143.00 |
| Jun 30, 2025 | 193,775.00 |
| Dec 31, 2021 | 530,196.00 |
| Sep 30, 2021 | 507,638.00 |
| Jun 30, 2021 | -151,029.00 |
| Mar 31, 2021 | -318,285.00 |
| Dec 31, 2020 | -148,816.00 |
| Sep 30, 2020 | -176,887.00 |
| Jun 30, 2020 | -32,612.00 |
| Mar 31, 2020 | -7,625.00 |
| Dec 31, 2019 | 134,947.00 |
| Sep 30, 2019 | 123,799.00 |
| Jun 30, 2019 | 94,380.00 |
| Mar 31, 2019 | 130,343.00 |
| Dec 31, 2018 | -345,402.00 |
| Sep 30, 2018 | 35,687.00 |
| Jun 30, 2018 | -46,190.00 |
| Mar 31, 2018 | -89,102.00 |